-+ 0.00%
-+ 0.00%
-+ 0.00%

BioHarvest Sciences Affirms FY2026 Sales Guidance of $42.000M-$48.000M vs $44.721M Est

Benzinga·05/14/2026 11:24:01
Listen to the news
BioHarvest Sciences (NASDAQ:BHST) affirms FY2026 sales outlook from $42.000 million-$48.000 million to $42.000 million-$48.000 million vs $44.721 million estimate.